Since the publication of the human reference genome, the identities of specific genes associated with human diseases are being discovered at a rapid rate. A central problem is that the biological activity of these genes is often unclear. Detailed investigations in model vertebrate organisms, typically mice, have been essential for understanding the activities of many orthologues of these diseaseassociated genes. Although gene-targeting approaches 1-3 and phenotype analysis have led to a detailed understanding of nearly 6,000 protein-coding genes 3, 4 , this number falls considerably short of the more than 22,000 mouse protein-coding genes 5 . Similarly, in zebrafish genetics, one-by-one gene studies using positional cloning 6 , insertional mutagenesis [7] [8] [9] , antisense morpholino oligonucleotides 10 , targeted re-sequencing [11] [12] [13] , and zinc finger and TAL endonucleases [14] [15] [16] [17] have made substantial contributions to our understanding of the biological activity of vertebrate genes, but again the number of genes studied falls well short of the more than 26,000 zebrafish protein-coding genes 18 . Importantly, for both mice and zebrafish, none of these strategies are particularly suited to the rapid generation of knockouts in thousands of genes and the assessment of their biological activity. Here we describe an active project that aims to identify and phenotype the disruptive mutations in every zebrafish protein-coding gene, using a well-annotated zebrafish reference genome sequence 18, 19 , high-throughput sequencing and efficient chemical mutagenesis. So far we have identified potentially disruptive mutations in more than 38% of all known zebrafish proteincoding genes. We have developed a multi-allelic phenotyping scheme to efficiently assess the effects of each allele during embryogenesis and have analysed the phenotypic consequences of over 1,000 alleles. All mutant alleles and data are available to the community and our phenotyping scheme is adaptable to phenotypic analysis beyond embryogenesis.
Over the past 9 years we have aimed to establish methods for the systematic identification of disruptive mutations in zebrafish. Given the lack of complete annotation at early stages of the project we originally used a reverse genetic approach known as TILLING to identify mutations in specific genes by sequencing polymerase chain reaction (PCR)-amplified exons from thousands of N-ethyl-Nnitrosourea (ENU) mutagenized individuals [11] [12] [13] 20 . With the advent of high-throughput sequencing methods we were able to substantially increase the throughput of this approach but never reached genomewide coverage of exons 11 .
After the release of the Zv8 and Zv9 assemblies of the zebrafish genome and their protein annotations, we were able to design reagents to extract the annotated exons from zebrafish genomic DNA, enriching for approximately 60 megabase pairs (Mbp) of exome sequence and covering all 26,206 protein-coding genes 18, 19 (Fig. 1 ). We increased sequencing throughput by pre-capture pooling up to eight barcoded F 1 genomic libraries and combining the exon-enriched DNA into a single high-throughput sequencing sample, while retaining adequate sequencing coverage and depth to identify heterozygous induced mutations ( Supplementary Table 1 ). By sequencing the exon-enriched DNA from mutagenized F 1 individuals, we are able to identify ENUinduced mutations using a modified version of the 1000 Genomes *These authors contributed equally to this work. 1 project variant-calling pipeline 21, 22 . For each F 1 we predict the proteincoding consequences of the induced mutations, and for each nonsense and essential splice-site mutation we generate a single nucleotide polymorphism (SNP) genotyping assay 11 to facilitate the identification of each mutation in subsequent generations. We are able to confirm 95% of candidate mutations in subsequent generations. We analysed the exome sequences of 1,673 mutagenized F 1 individuals and identified 12,002 induced nonsense and 5,337 induced essential splice mutations in 10,043 genes. For 4,105 genes we identified two or more disruptive alleles (Supplementary Table 2 ). With this set of data we can make predictions about the number of F 1 individuals we will need to analyse to obtain disruptive mutations in each protein-coding gene. The detection of nonsense and essential splice mutations in new genes gradually decreased over the 1,673 sequenced individuals ( Fig. 2a ), such that the ratio of mutations in new genes to alleles was 1 for the first 10 sequenced exomes but 0.37 for the last 10 exomes. On average, each individual contained 125 nonsense and 168 essential splice mutations, which were common to the strains used, and among the induced mutations were 7 nonsense, 3 essential splice and 90 non-synonymous mutations (Supplementary Table 3 ). As the number of induced non-synonymous mutations within each individual was approximately 10 times the sum of nonsense and essential splice mutations ( Fig. 2b) , the rate of detecting non-synonymous mutations in new genes decreased more rapidly over the 1,673 exomes, with the ratio of non-synonymous mutations in new genes to alleles being 0.024 for the last 10 exomes. Sequencing 808 individuals resulted in the identification of 85,338 non-synonymous alleles, corresponding to mutations in 75% of all known protein-coding genes. We predict that at least 1 disruptive mutation will be identified in 75% of protein-coding genes by sequencing approximately 8,000 F 1 individuals.
To draw the most value from this resource, it is important to identify any phenotypic consequence of homozygous mutations. Thus, we have established a high-throughput, systematic phenotypic analysis of alleles to assess the developmental consequences of any given mutation. We have focused our efforts on induced nonsense and essential splice mutations. In a two-step, multi-allelic, phenotyping approach, we first identify those mutations that do not cause a phenotype within the first 5 days post fertilization (d.p.f.) in F 3 embryos ( Fig. 3 ) collected from crosses of up to 12 pairs of F 2 individuals (Fig. 3b ). We genotype phenotypically normal F 3 embryos at 5 d.p.f. for all mutations identified as heterozygous in both F 2 parents ( Fig. 3c ). Homozygous mutations present in the expected Mendelian ratios among F 3 embryos a b individuals were outcrossed to produce an F 2 family. The induced disruptive alleles for one family are shown. b, F 2 individuals were incrossed and genotyped. c, First round, embryos with wild-type phenotypes were collected from each clutch at 5 d.p.f. and genotyped for the mutations heterozygous in both parents. The number of homozygous mutant F 3 embryos was assessed using a chi-squared test (P values of less than 0.05 were considered statistically significant). Mutations homozygous in less than 25% of embryos were suspected to cause a phenotype.
In the wild-type phenotype set there were no homozygous embryos for the alleles slc22a7b sa365 , mphosph10 sa371 and lamc1 sa379 . d, e, Second round, phenotypes present within each incross were genotyped for putative phenotypic mutations. d, slc22a7b sa365 shows pigment phenotype. e, mphosph10 sa371 shows small head and pericardiac oedema phenotype. lamc1 sa379 mutants are shown in Fig. 4l , n.
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are documented as not causing a phenotype at 5 d.p.f. Homozygous mutations present in less than 25% of phenotypically normal embryos are suspected to cause a phenotype (Fig. 3c ).
In the second step of analysis, we test for correlations between the predicted disruptive mutations and morphological phenotypes ( Fig. 3d, e ). We re-cross the F 2 adults that are heterozygous for the suspected causal mutation and examine the F 3 embryos for all morphological and behavioural phenotypes during the first 5 d.p.f. All phenotypes are genotyped for the given mutation and if, for a given phenotype, over 90% of embryos are homozygous for the specific mutation, it is documented as likely to be causal ( Fig. 3d, e ), with 10% tolerance for pipetting and genotyping errors. If less than 90% of embryos with one phenotype are homozygous for the mutation of interest, it is documented as being linked to a phenotype rather than causative.
We have carried out a phenotypic analysis of 1,216 nonsense and essential splice mutations. Of these, 48 mutations caused a phenotype within the first 5 d.p.f. and 77 alleles were linked to a phenotype. Among the predicted disruptive mutations, 1,065 were deemed to have no phenotype at 5 d.p.f. and 26 are under further investigation. For all phenotype-genotype correlations we annotated each of the phenotypic traits using developmental stage, anatomical entity and phenotypic quality terms to enable phenotype data mining.
This mutation discovery and the multi-allelic phenotyping pipeline systematically annotates zebrafish gene function. Importantly, the described genotype and phenotype correlations do not constitute proof of causality for the individual allele. Detailed aetiology of a phenotype-genotype correlation can only be proven by more exhaustive investigation, such as a complementation test. By combining two distinct potentially disruptive mutations in the same gene using a compound cross of two independent heterozygous carriers and carrying out a genotype analysis of the expected single-phenotype F 3 embryos, we can rule out linked mutations independently associated with each allele. In cases in which a phenotype and allele have been associated and additional alleles in the same gene are available, we perform complementation crosses to prove causality (Fig. 4) .
We find that approximately 6% (74 out of 1,216) of alleles are phenotypic, and this percentage is low in comparison to measurements of mouse embryonic lethality 23 . There are several possible explanations. First, the alleles generated and analysed in this project are random point mutations across the length of each gene. Therefore, a proportion of alleles do not disrupt-or only partially disrupt-protein function. However, the position of a mutation is not necessarily a good predictor of the severity of disruption (demonstrated by the alleles described in Fig. 4d, h, 24, 25 . For example, individuals homozygous for mutations in titin a (ttna) ( Fig. 4i-k) show a phenotype distinct from the published ttnb mutant runzel 26 . It is unlikely that a comprehensive functional understanding of all human protein-coding genes will become available in the near future. Therefore, by providing a systematic analysis of zebrafish gene function, with phenotypes annotated in searchable, ontology-based data sets, the reagents described here will advance our knowledge of the biological basis for human disease. So far we have identified mutations in the orthologues of 3,188 of the 5,494 genes currently associated with human disease in genome-wide association studies (http://www.genome. gov/gwastudies) and have identified at least 1 allele in 2,505 of the 4,204 genes associated with a human phenotype in the Online Mendelian Inheritance in Man database (http://www.omim.org).
Our analysis will provide a rich resource for developmental biologists and clinicians to facilitate the identification of candidate genes for idiopathic inherited diseases or pathogen susceptibility. Furthermore, the alleles and data generated by this project are available to the scientific community through our website (http://www.sanger.ac.uk/Projects/ D_rerio/zmp) and alleles will be available from two international stock centres, the Zebrafish International Resource Center (http://www. zebrafish.org/zirc) and the European Zebrafish Resource Center (http:// www.itg.kit.edu/ezrc). Information on how to use these facilities can be found in the Supplementary Information. We believe that the work described here will substantially enhance the use of zebrafish as a model organism to study vertebrate development and human disease.
METHODS SUMMARY
Exon coordinates (Zv8 and later Zv9) were used to design the Agilent SureSelect baits. DNA was prepared from fin biopsies of F 1 progeny from mutagenized individuals, and barcoded Illumina sequencing libraries (150-200-bp insert size) were prepared and hybridized to the SureSelect baits. Exome-enriched libraries were amplified by PCR and subjected to 54-bp paired-end Illumina sequencing. Sequences were analysed using a custom computational pipeline to identify nonsense and essential splice mutations induced by the mutagenesis. Phenotyping was carried out by in-crossing up to 12 pairs of F 2 adults. Each breeding pair was fin clipped and genotyped for the induced nonsense and essential splice mutations that were detected in the F 1 exome sequence. From each breeding pair, 150 F 3 embryos were sorted into 3 dishes. Embryos were incubated at 28.5 uC and previous mutagenesis screens were used as a reference for the phenotyping 27, 28 . In the first round of the phenotyping, 48 phenotypically normal embryos were collected at 5 d.p.f. Embryos were then genotyped for the mutations that were heterozygous in both F 2 adults. In the second round, F 2 individuals that were heterozygous for a mutation suspected to cause a phenotype were re-crossed and the F 3 embryos were studied for phenotypes on all of the first 5 d.p.f. Phenotypic and non-phenotypic embryos were then genotyped for the mutation of interest. Genotyping was carried out using the KBioscience competitive allele-specific PCR (KASP) genotyping system.
METHODS
Exome sequencing and SNP calling. Adult male zebrafish were mutagenized using ENU according to improved mutagenesis protocols 11 . G 0 mutagenized individuals were outcrossed to create large F 1 mutagenized libraries. DNA was isolated from F 1 individuals by incubating fin biopsies in 400 ml of 100 mg ml 21 proteinase K for 10 h at 55 uC, and it was then incubated for 15 min at 85 uC to heat-inactivate the proteinase K. DNA was precipitated by adding 400 ml of isopropanol and centrifuging for 30 min at 2,700g and 4 uC. DNA pellets were washed twice with 400 ml of 70% ethanol followed by centrifugation at 4,000 r.p.m. for 5 min, and resuspended in ddH 2 0. DNA from each individual (1-2 mg) was sheared and used to construct 150-to 200-bp-insert Illumina libraries according to the manufacturer's standard protocols.
For the rapid identification of ENU-induced mutations in individual zebrafish covering all annotated zebrafish protein-coding genes, we developed a wholeexome enrichment reagent using Agilent SureSelect. RNA oligonucleotides, 120 bases in length, were designed across the predicted exon coordinates to cover each base twice (23 tiling) and then manufactured as biotinylated RNA baits and blended into one tube, ready for enrichment. After completion of a pilot experiment to evaluate the technology, we developed an exome design using the Ensembl 61 (Zv9) gene set, which included a total of 60 Mbp of coding sequence and 26,206 genes 18, 19 .
For each F 1 genomic Illumina library, 500 ng of DNA was hybridized for 24 h to biotinylated whole exome RNA baits. Hybridized fragments were enriched using streptavidin-coated beads, RNA was digested, and remaining libraries of fragments were amplified for 10 cycles using standard Illumina primers with or without indexing barcodes. The resulting amplified libraries were run on Illumina GAII or HiSeq2000 machines using GAII, HiSeq2000v2 or HiSeq2000v3 chemistries to perform 54-bp paired-end sequencing.
Initially, each enriched sample was sequenced on an individual lane of an Illumina GAII machine using 54-bp paired-end runs, achieving a mean of 64 million reads per sample ( Supplementary Table 1 ). Of those reads, 55% mapped to the exome target sequence, with 90% of the target being covered at 43 and 64% covered at 203. For the identification of SNP variants, at least 43 coverage was required, with 203 coverage providing the number of reads required for reliable mutation detection 29 . We subsequently moved to the HiSeq platform, incorporated barcoding into the production of the library and carried out pre-capture pooling of libraries. These improvements enabled us to sequence eight exomes on an individual lane, consequently increasing the throughput and lowering costs (Supplementary Table 1 ). These results show that we could efficiently enrich and sequence the zebrafish exome at the coverage required for reliable mutation detection in a cost-effective manner.
We identified ENU-induced mutations within the exome sequences using a modified version of the 1000 Genomes Project variant-calling pipeline 21 . Paired reads were aligned to the Zv9 reference assembly using the Burrows-Wheeler Aligner (BWA), and SNPs were called by SAMtools mpileup, QCALL and the GATK Unified Genotyper. SNPs that were not called by all three callers were removed from the analysis, along with any SNP that did not pass a caller's standard filters. In addition, SNPs were removed in cases in which the total read depth was less than the number of samples and if the genotype quality was lower than 100 for GATK and lower than 50 for QCALL and SAMtools mpileup. Finally, SNPs within 10 bp of an indel (called by both SAMtools mpileup and Dindel) were removed. Variation consequences were assigned by the Ensembl Variant Effect Predictor 30 using the Ensembl 61 gene set. An SNP was defined as an induced mutation if present in one to three individuals, as this allowed for founder effects that may have arisen from the mutagenesis. If the SNP was present in more than three individuals it was considered to be common to the strain used. Heterozygous calls that were found in one to three samples only were deemed to be induced mutations and those with a nonsense consequence (Sequence Ontology accession SO:0001587) or essential splice consequence (SO accessions: SO:0001574 and SO:0001575) were used to design KASP assays.
In a pilot run, using a sample of six individual exomes, we confirmed all induced mutations that were called by at least two of the SNP callers by both KASP genotyping and capillary sequencing to calculate the false positive rate of our analysis (data not shown). These genotyping results were used to set filtering parameters within our SNP calling pipeline, such that 85.7% of SNPs that could not be confirmed by KASP genotyping or capillary sequencing were removed. Information on common SNPs, and insertions and deletions, were also collected so that they could be avoided when designing genotyping assays.
To estimate the mutation saturation we used missense mutations, which are present in F 1 individuals at a tenfold higher rate than induced nonsense and essential splice-site mutations combined. As each mutagenized library displayed different rates of mutagenesis, the order that exomes were sequenced was randomized in the analysis.
We reasoned that the induced nonsense and essential splice mutations were more likely to result in putative loss-of-function alleles than non-synonymous mutations. Moreover, we did not include non-synonymous mutations for the phenotypic analysis on the assumption that if they are truly loss-of-function alleles, sequencing more individuals will eventually give a nonsense or essential splice allele in those genes. Phenotyping. Zebrafish were maintained in accordance with UK Home Office regulations, UK Animals (Scientific Procedures) Act 1986, under project licence 80/2192, which was reviewed by the Wellcome Trust Sanger Institute Ethical Review Committee.
Heterozygous F 2 fish were randomly incrossed, and after egg collection F 2 adults had their fins clipped, were genotyped for the induced nonsense and essential splice mutations identified in the F 1 exome sequence, and kept as isolated breeding pairs. For each family we aimed to phenotype 12 pairs over 3 weeks of breeding. Each clutch of eggs, which was labelled with the identification numbers of the breeding pair, was sorted into three 10-cm Petri dishes containing approximately 50 embryos each. Embryos were incubated at 28.5 uC. Previous mutagenesis screens were used as a reference for the phenotyping 27, 28 . The phenotypes studied were: day 1, early patterning defects, early arrest, notochord, eye development, somites, patterning and cell death in the brain; day 2, cardiac defects, circulation of the blood, pigment (melanocytes), eye and brain development; day 3, cardiac defects, circulation of the blood, pigment (melanocytes), movement and hatching; day 4, cardiac defects, movement, pigment (melanocytes) and muscle defects; day 5, behaviour (hearing, balance, response to touch), swim bladder, pigment (melanocytes, xanthophores and iridophores), distribution of pigment, jaw, skull, axis length, body shape, notochord degeneration, digestive organs (intestinal folds, liver and pancreas), left-right patterning.
In the first round of phenotyping, all phenotypic embryos were discarded. At 5 d.p.f. more than 48 phenotypically wild-type embryos were collected. Embryos were fixed in 100% methanol and stored at 220 uC until genotyping for nonsense and essential splice mutations heterozygous in both parents was initiated. If 6 or more out of 48 embryos in the first round of genotyping were homozygous (corresponding to a P value of more than 0.05 in a chi-squared test and indicating no statistically significant difference compared to the expected 25% ratio) the allele was deemed not to cause a phenotype within the first 5 d.p.f. If the number of homozygous embryos was 5 or fewer (corresponding to a P value of less than 0.05 in a chi-squared test), then the allele was carried forward into the second round of phenotyping.
In the second round, F 2 individuals that were heterozygous for a suspected causal mutation were re-crossed to obtain clutches containing embryos homozygous for suspected causal mutations. All phenotypes observed in those clutches of embryos were counted, documented and photographed. Phenotypic embryos were fixed in 100% methanol and at 5 d.p.f. 48 wild-type phenotype embryos were also collected. All embryos were genotyped for the suspected causal mutations. An allele was documented as causing a phenotype if the phenotypic embryos were homozygous for the allele and the non-phenotypic sibling embryos were heterozygous or homozygous for the wild-type. For each allele we accepted up to 10% of phenotypic embryos to be not homozygous, to account for errors in egg collection. Such alleles were outcrossed for further genotyping with F 4 embryos later. If possible, alleles were also submitted to complementation tests. Genotyping. Embryo DNA was prepared by first removing the embryos from 100% methanol, and individual embryos were then placed into wells of a 96-well plate. The well positions of phenotypic and non-phenotypic embryos were documented. Incubating the plate at 80 uC for 15 min evaporated all remaining methanol. DNA was extracted from embryos by incubating in 25 ml of lysis buffer (25 mM NaOH with 0.2 mM EDTA) at 95 uC for 30 min. After this, a volume of 25 ml of neutralization buffer (40 mM Tris-HCl) was added. Genotyping was carried out using the KASP genotyping system (KBioscience). Clipped fins and embryo DNA were diluted to a working concentration of 1.25-12.5 ng ml 21 . A volume of 4 ml of DNA was pipetted into black 384-well hard shell PCR plates and dried at 20 uC. When genotyping was carried out, the DNA was re-suspended by adding a 4-ml PCR mix, according to the manufacturer's protocol (KBioscience). PCR results were analysed using PHERAstar plus (BMG labtech) and the software KlusterCaller (KBioscience). Cryopreservation of alleles. Sperm from individual males was collected by abdominal massage into 10-ml glass capillaries. The sperm were expelled into 245 ml 10% N,N-dimethylacetamide (DMA) in BSMIS (75 mM NaCl, 70 mM KCl, 2 mM CaCl 2 , 1 mM MgSO 4 , 20 mM Tris, pH 8.0) and mixed briefly by pipetting up and down. Eight aliquots of 35 ml each were pipetted directly into 2-ml cryovials and transferred immediately into a pre-chilled 50-ml Falcon tube on a dry ice and ethanol bath. After 30 min the samples were moved into liquid nitrogen for long-term storage. Storage location, date of collection and sample RESEARCH LETTER
